Logo

Delfi Diagnostics: Doug Schenkel

Oct 07, 2021

Delfi Diagnostics has appointed Doug Schenkel its CFO. He joins Delfi from investment bank Cowen where he was most recently managing director and senior analyst, leading the life science and diagnostic tools franchise. In that role, Schenkel covered more than 50 companies for more than 20 years. Cowen Chair and CEO Jeffrey Solomon said in a statement that Schenkel will remain as a senior advisor to the bank as he transitions to Delfi.

Breaking News
The Scan

Tara Pacific Expedition Project Team Finds High Diversity Within Coral Reef Microbiome

In papers appearing in Nature Communications and elsewhere, the team reports on findings from the two-year excursion examining coral reefs.

Study Examines Relationship Between Cellular Metabolism, DNA Damage Repair

A new study in Molecular Systems Biology finds that an antioxidant enzyme shifts from mitochondria to the nucleus as part of the DNA damage response.

Stem Cell Systems Target Metastatic Melanoma in Mouse Model

Researchers in Science Translational Medicine describe a pair of stem cell systems aimed at boosting immune responses against metastatic melanoma in the brain.

Open Pediatric Brain Tumor Atlas Team Introduces Genomic Data Collection, Analytical Tools

A study in Cell Genomics outlines open-source methods being used to analyze and translate whole-genome, exome, and RNA sequence data from the Pediatric Brain Tumor Atlas.